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XII EXPANSION OF 
ABBREVIATIONS 
INTRODUCTION
Cry  of  a  child  is  the  most  enchanting  symphony  that  could  be  ever 
heard  in  any house.  On  the  other  hand,  adverse  outcome  after  a  completed 
term  pregnancy  has  severe  emotional  and  psychological  trauma  to  both  the 
patient and obstetrician. All the available tests for antepartum and intrapartum 
fetal well being are aimed at a common goal of delivering a healthy child with 
not trace of hypoxia.
The  days  where  caesareans  were  performed  for  dead  fetuses  have 
become historical.  In the last  century,  we have witnessed several  monitoring 
methods  to  diagnose  fetal  distress  where  immediate  intervention  has  been 
rewarding.  However  today,  the  tests  are  aimed  in  detecting  the  fetuses  who 
are prone for distress rather than detecting the fetal distress perse.
Routine  antepartum  fetal  surveillance  is  mandatory  in  patients  with 
high  risk  pregnancies,  in  which  the  testing  protocols  attends  to  distinguish 
fetuses  that  can  be  safely managed expectantly from fetuses  that  need  to  be 
delivered  promptly  to  prevent  perinatal  morbidity  and  mortality.  However 
intrapartum  fetal  surveillance  is  a  must  for  all  pregnant  patients  in  labour 
(even in  pregnancies  posed with no risk).  Since  intrapartum events  by itself 
places the fetuses under the stress of labour. And there is a good evidence that 
the stress of labour in term of fetal hypoxia and metabolic acidosis can lead to 
cerebral  damage and fetal  death  and  that  such  insults  are  not  limited  to  the 
pregnancies determined as high risk by virtue of maternal disease or antenatal 
placental compromise (Skyes et al., 1983).
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The predominant goal of antepartum and intrapartum fetal testing is to 
lower  perinatal  morbidity  and  mortality  rates.  To  accomplish  this  goal, 
physicians need to know which fetuses are at  risk, what test  are available to 
assess  them and how often to  use the tests.  Unfortunately,  we will  never  be 
able to reduce perinatal mortality to zero. Some causes of fetal death, such as 
cord  accidents  and  maternal  trauma,  cannot  be  predicted  in  advance.  In 
addition, congenital anomalies which contribute significantly to perinatal and 
neonatal mortality rates, cannot be entirely prevented.
The biophysical  profile  and  the  NST has  been  reaching  the  near  gold 
standard.  Fetal  vibro  acoustic  stimulation  or  scalp  stimulation  should  be 
considered  as  one  facet  of  comprehensive  fetal  evaluation.  When  these 
techniques  are  used  in  this  manner  the  clinician  evaluating  the  fetus  in  the 
antepartum or  intrapartum period  may prevent  unnecessary  intervention  and 
improve maternal and neonatal outcome. In the present study, VAST is being 
evaluated in predicting the fetal outcome in high risk pregnancies.
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 AIM OF THE STUDY
1. To evaluate the role of VIBRO-ACOUSTIC STIMULATION TEST to 
discrimate the compromised from the non compromised fetus in high – 
risk pregnancies in early intrapartum period.
2. To  evaluate  the  effectiveness  of  VAST  in  predicting  the  adverse 
perinatal outcome in high risk pregnancies
8
REVIEW OF LITERATURE 
HISTORY
It  was  not  until,  1818  that  FRANCOSIS  ISSAC,  Mayor  of  Geneva,  a 
surgeon, reported the fetal heart audibly different from the maternal pulse by applying 
the ear directly to the pregnant mothers abdomen.
LAENNEC,  a  physician  working  in  Paris  (1806),  was  the  father  of  the 
technique of auscultation of the adult heart and lungs.
JOHN  CREERY  FERGUSON,  the  first  professor  of  Medicine  at  the 
Queen’s University of Belfast, in 1827 was the first person in Britain to describe the 
fetal heart sounds.
ANTON FRIEDRILH HOHL was the first to describe the design of the fetal 
stethoscope in 1834.
Although  PINARD’S name  is  most  commonly  associated  with  the 
stethoscope, his version followed several others, only appearing in 1876.
WINKEL in 1893 empirically set the limits of the normal heart rate at 120 
b.p.m. to 160 b.p.m.
In  1958 HON pioneered electronic fetal monitoring in the USA.
Abdominal electrocardiography was introducted by CREMER in 1906. But it 
was only in 1974 that this method became commercially available.
REYNOLDS  et  al.,  (1941)  were  the  first  to  devise  an  external 
tocodynamometer for external registration of uterine contractions.
9
Intrauterine  pressure  can  also  be  recorded  using  a  catheter  inserted 
transcervically.  This  method  was  first  described  by  WILLIAM and 
STALLWORTHY in 1952.
CALDEYRO BRACIA  et  al., (1950)  described  recording  of  intrauterine 
pressure by transabdominally inserted devices.
Vibro  –  acoustic  stimulation  test  was  added  to  the  ante  –  partum  and 
intrapartum fetal surveillance in late 1970s and it was not until 1984 that external 
sound was used to arouse the quiet fetus, eliciting a startle response. 
Radiotelemetry  –  This  technology  is  now  available  to  record  F.H.R.  and 
uterine  contraction  on  a  centrally  located  monitor  while  the  patient  is  either 
ambulatory in the hospital or some times even at home. This is done by utilizing a 
special  equipment  which  allows  the  F.H.R.  and  uterine  contraction  signals  to  be 
transmitted over long distances.
CONTROL OF THE FETAL HEART
Control  of the fetal  heart  is  complex.  The fetal  heart  has  its  own intrinsic 
activity and a rate determined by the spontaneous activity of the pacemaker in the 
S.A. node. This structure has the fastest rate and determines the rate in the normal 
heart. The next fastest pacemaker is in the atrium. The AV node has the slowest rate 
of activity and generates the idioventricular rhythm seen in complete heart block. 
The  fetal  heart  is  modulated  by  a  number  of  stimuli.  CNS  influence  is 
important  with  cortical  and  subcortical  influences  which  is  not  under  voluntary 
control.  The  cardiorespiratory  centre  in  the  brain  stem  also  play  a  part.  Other 
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physiological  factors  regulate  the  heart  rate  such  as  circulatory  catecholamines, 
chemoreceptors, baroreceptors and their interplay with ANS.
VARIOUS TESTS FOR ASSESSING FETAL WELL BEING
Fetal movement counts. 
Maternal perception of fetal movement is an expensive, non-invasive method 
of assessing fetal well being. This test can be performed in various ways. Generally 
the patient is asked to relax on her left side, 30 min after eating and to concentrate on 
FM. The patient should record the time, she starts the test and note each time the baby 
kick or moves. A healthy fetus should move approximately 3 to 5 times within one 
hour in this setting.
An alternative method is the “Cardiff” count to ten chart, whereby the patient 
records fetal  movements during the course of usual daily activity.  A period of 12 
hours without atleast 10 perceived movements is considered a warning signal. If the 
test  result  is  not  reassuring,  the  patient  should  be  evaluated  and  should  undergo 
further testing such as evaluation with NST.
Studies have shown that FM counts are an effective screening measure with 
reported reductions in fetal mortality from 8.7 deaths / 1000 live birth to 2.1 death / 
1000 live birth.
Although the  ideal  method for  performing the  test,  including  how often  it 
should be repeated, has not been defined, it is clear that complaints of decreased FM 
are  significant  and  warrant  further  evaluation.  The  use  of  fetal  kick  counts,  as  a 
primary testing tool remains controversial since this method of fetal surveillance is 
neither standardized nor proven in large prospective randomized trials.
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Non – Stress Test
The non-stress test is an indirect measurement of utero-placental function. The 
test requires specialised equipment and trained personnel.
The patient is usually seated in a reclining chair (Fowlers’ position), slightly 
titled to the left to avoid supine hypotension. A Doppler ultrasound transducer and a 
tocodynamometer  are  used  to  monitor  the  fetal  heart  rate  and  uterine  activity 
simultaneously. Fetal movements can also be recorded during the test.  The patient 
presses a button that makes a mark on the tracing every time she perceives a fetal 
movement. A reassuring or reactive, non-stress test exhibits at least two accelerations 
in the fetal heart rate in a 20-minute period that are at least 15 beats per minute above 
the  baseline  and  last  atleast  15  seconds  A non-reactive  test  does  not  meet  these 
criteria.
Fetal heart  rate reactivity is a reflection of the balance between the fetus’s 
sympathetic and parasympathetic tone.  It  is  an acquired neurological reflex and is 
therefore dependant on gestational age: about 65 percent of healthy fetuses will have a 
reactive non-stress test at 28 weeks of gestation, 85 percent at 32 weeks of gestation 
and 95 percent at 34 weeks of gestation.
Fetal  heart  rate  accelerations  are  coupled  to  fetal  movement  as  the  fetus 
matures; consequently, they will be seen more frequently when the fetus is awake or 
in  an  active  sleep.  Since  fetuses  can  have  normal  sleep  cycles  lasting  up  to  40 
minutes, a non stress test might require over an hour to complete if it is initially non-
reactive. It is important to differentiate whether a non-reactive tracing truly represents 
a compromised fetus or merely reflects a temporary behavioural state. This can often 
be accomplished either by extending the test or by using additional testing modalities.
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Other factors that may be responsible for a non-reactive test are maternal use 
of sedatives or narcotics, as well as severe fetal anomalies of the cardiovascular or 
central nervous system.
As  originally  designed,  the  non-stress  test  involved  the  detection  of 
accelerations associated with perceived fetal movements. Subsequent studies showed 
that these accelerations are predictive of fetal well being regardless of the presence of 
maternaly perceived fetal movement. A non-reactive non-stress test suggests that the 
fetus may be compromised, and further studies are indicated to evaluate fetal well 
being.
Contraction Stress Test
The contraction stress test, also referred to as the oxytocin challenge test, is 
more cumbersome to perform and more costly than the non-stress test; it also presents 
more  risks.  However,  this  test  may  identify  fetuses  that  are  only  marginally 
compromised  by  assessing  their  reserve  when  subjected  to  the  stress  of  uterine 
contractions. The goal of the test  is  to achieve three uterine contractions in a 10-
minute period. This can occur spontaneously, with the aid of nipple stimulation, or 
with an oxytocin infusion.
With nipple stimulation the patient is instructed to stroke the nipple for two minutes 
followed by 5 minute period of rest. The cycle is repeated until adequate contractions 
are observed. If oxytocin is used, it should be started at an Infusion rate of 0.5 to 1.0 
mU per minute and doubled every 15 minutes until the desired contraction pattern is 
achieved. The test carries a small risk of uterine hyperstimulation.
The test  is  considered  negative  if  no late  decelerations  are  observed.  It  is 
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considered positive if late decelerations are detected with more than 50 percent of the 
contractions. The test should raise suspicion if an occasional late deceleration is seen. 
A late deceleration is a decrease in fetal heart rate that occurs after the peak of a 
contraction and returns to baseline after the contraction has subsided. The latter two 
findings are more ominous if the tracing is also nonreactive. If variable decelerations 
occur,  an  Ultrasound  examination  should  be  performed  to  assess  amniotic  fluid 
volume. Variable decelerations are decreases in fetal heart rate that usually occur at 
the same time as a contraction and vary in duration and drop in heart rate.
Biophysical Profile
The biophysical profile was first introduced in the late 1970s. Because it is an 
ultrasonographic assessment of fetal behavior, it requires more expensive equipment 
and more highly trained personnel than the other testing modalities.
The study is based on the concept that hypoxic fetuses lose certain behavioural 
parameters in the reverse order in which they were acquired in the course of fetal 
development It evaluates indicators of CHRONIC FETAL HYPOXIA and placental 
function, such as amniotic fluid volume, in addition to more ACUTE INDICATORS, 
such as fetal breathing, movements and tone. The biophysical profile is a scored test 
with five components, each of which is worth 2 points if present, given in Table.
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COMPONENTS OF THE BIOPHYSICAL PROFILE
Parameters Normal (score = 2) Abnormal (Score =0)
Non – stress test Greater than or equal to 2 
acceleration greater than or equal 
to 15 beats per minute above 
baseline during test lasting greater 
than or equal to 15 seconds in 20 
minutes
< 2 qualifying acceleration 
during test
Amniotic fluid test AFI * greater than or equal to or at 
least 1 pocket measuring 2 cms x 
2cm in perpendicular plane
AFI < 5 or no pocket > 
2cm x 2cm
FBM Sustained FBM (≥ 30 seconds) Absence of FBM or short 




≥ 3 episodes of either limb or trunk 
movement 
> 3 episodes during test
Fetal tone Extremities in flexion at rest and ≥ 
1 episode of extension of 
extremity, hand or spine with 
return to flexion
Extension at rest or no 
return to flexion after 
movement
AFI = amniotic fluid index; FBM = fetal breathing movement
* Amniotic fluid index = the sum of the largest vertical pocket in each of four 
Quardrants on the maternal abdomen intersecting at the umbilicus.
A score of 8 to 10 points considered reassuring. A score of 6 points is 
suspicious and indicates the need to further evaluation. A score of 4 points or less is 
ominous and indicates the need for immediate intervention.
Modified Biophysical Profile
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An alternative to the biophysical profile is a combination of the Non-Stress 
Test and an assessment of Amniotic Fluid Volume so-called Modified Biophysical 
Profile. Such a test provides a means of evaluating the acute condition of the fetus and 
long-term utero-placental  function.  It  has  been shown to be  as  effective as  a  full 
biophysical profile in assessing fetal well being.
Vibro-acoustic Stimulation Test
Vibro-acoustic stimulators are artificial larynxes that generate sound pressure 
levels of approximately 80 to 100 decibels when applied in two or three one-second 
bursts to the maternal abdomen near the fetal head. This essentially wakes a sleeping 
fetus, thereby changing its behavioural state. Vibro-acoustic stimulation (VAS) is an 
easy, relatively inexpensive way to shorten testing times and reduce the false-positive 
rates for non-stress test and biophysical profiles. Fetuses that respond to VAS with an 
acceleration on a non-stress test or a startle response on a biophysical profile have 
very low rates of death within one week of the test.
 FETAL NEURODEVELOPMENT AND SEQUENCE OF FETAL
DETERIORATION
Fetal Neurodevelopment
Tone (Cortex/Sub cortex - 7.5 to 8.5 weeks)
Movement (cortex / nuclei-9 weeks)
Breathing (ventral surface of fourth Ventricle 20-2 1 weeks)
Fetal heart rate reactivity. (Posterior Hypothalamus-Medulla - 24 weeks)
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Sequence of fetal deterioration
Late decelerations appear (CST)
Accelerations disappear (NST, BPP, CST)
Fetal breathing stops (BPP)
Fetal movement stops (BPP)
Fetal tone• absent (BPP)
Amniotic fluid decreases (chronic hypoxia resulting in redistribution
of cardiac output away from the kidneys towards the brain)
CST = Contraction Stress Test : NST = Non-Stress Test BPP = Biophysical Profile
Hypoxic fetuses lose certain behavioural  parameters in the reverse order in 
which they were acquired in the course of fetal development.
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STATISTICAL CHARACTERISTICS OF SELECTED ANTE-PARTUM 
FETAL TESTS
Characteristic NST CST BPP
Sensitivity Poor Average High
Specificity High High High
False-positive rate High High High
False-negative rate Low Low Average
NST = Non-Stress Test; CST = Contraction Stress Test
BPP = Biophysical Profile
FREQUENCY OF FETAL TESTING
Traditionally,  antepartum  testing  has  been  repeated  at  weekly  intervals. 
Several studies, however, have shown improved outcomes with twice-weekly testing, 
particularly when the non-stress test is used as the primary screening modality. More 
frequent  testing  is  indicated  in  some  very-high-risk  situations  in  which  rapid 
deterioration  of  the  fetal  condition  can  occur,  such  as  preterm  rupture  of  the 
membranes, severe intrauterine growth restriction with oligohydramnios, and severe, 
acute maternal illness. General guidelines for antepartum testing are given in Table 5. 
It is important for the physician to establish an individual protocol for each pregnant 
patient based on a risk assessment and gestational age.
GENERAL GUIDELINES FORANTEPABTUM TESTING
Indication Initiation Frequency
Post-term pregnancy 40 weeks Twice a week
Preterm rupture of the membranes At onset Daily
Bleeding 26 weeks or At onset Twice a week
Oligohydramnios 26 Weeks orAt onset Twice a week
Polyhydramnios 32 Weeks Weekly
Diabetes
Class A 1 (well- controlled, No
complications) 32 Weeks Weekly
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Class A 2 (well- controlled, No
complications) 32 Weeks Twice a week
Class A or B with poor control, Class 
C- R 28 weeks Weekly
Chronic or Pregnancy – induced 
Hypertension 28 weeks Weekly
Steroid – dependent or poorly 
controlled Asthma 28 weeks Weekly
Collagen vascular disease including 
Anti-phospholipid antibody syndrome 28 weeks Weekly
Impaired renal function 28 weeks Weekly
Uncontrolled thyroid disease 32 weeks Weekly
Maternal heart disease (NHYA class 
III or IV) 28 weeks Once a week
Substance abuse 32 weeks Weekly
Cholestasis 32 weeks Weekly
Prior still birth Atleast before prior fetal death Weekly
Multiple gestation 32 weeks Weekly
Congenital anomaly 32 weeks Weekly
Significant isoimmunization 26 weeks Twice a week
Fetal growth restriction 26 weeks or at onset Once
External cephalic version At time of Procedure Once





NHYA = New York Heart Association
 
VIBRO – ACOUSTIC STIMULATION TEST
Introduction :
Fetal  stimulation has been used in  an effort  to  change the fetal  behavioral 
state, thereby inducing normal FHR monitoring patterns in non compromised fetuses. 
Reactive  FHR  patterns  induced  by  stimulation  have  been  shown  to  be  reliable 
indicators of fetal well – being.
Different types of stimuli have been studied in an attempt to change the fetal 
sleep  state  and  evoke  a  fetal  cardioacceleratry  response.  These  include  maternal 
administration of glucose, exposure to noise and external physical stimulation of the 
fetus.
Fetal  responses  to  environmental  noise,  characterized  by large  movements 
subjectively felt by the mother were documented by Peiper as early as 1925.  
In  1930s  fetal  movement  responses  were elicited  with  two boards  clapped 
together.
FHR accelerations and movements induced by vibroacoustic stimulation were 
first reported in 1936 by SONTAG and WALLACE. In the 1960s, fetal responses to 
various stimuli, including musical recordings and high – frequency puretones, were 
being studied more intensively.
GRIMWADE and co-workers detected acceleration of the FHR at term with 
an external heart  rate monitor after  stimulation with a loud speaker placed on the 
maternal abdomen. The stimuli consisted of the 20 second pulses of pure tones at 500 
to 1000 Hz applied 1 to 22 times. In antepartum patients at 38 to 42 weeks, heart rate 
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accelerations (mean of 27 bpm, lasting and average of 3.4 minutes) were detected in 
94% of fetuses.
Recently VAS has been suggested as an alternative to these methods.
The sound environment within pregnant uterus
This  has  been studied by placing miniaturized microphones  (Hydrophones) 
within the uterus during labour.
Internal noise
Intrauterine sound level has been reported to vary between 85 – 95 dB, with 
background noise level of about 60 dB. The sources of these noises are.
• Maternal vascular turbulence (peak sound is noted about 300ms after the R 
wave of maternal ECG).
• Maternal muscular activity 
• Maternal bowel sounds
External Noise
All external noises are attenuated by abdominal and uterine wall – particularly 
when the frequency of sound exceeds 1000 HZ with maximum attenuation at 4000 
Hz. Hence fetus does not receive noises of high frequency. However, it may be noted 
that external low frequency sounds of less than 125 HZ are enhanced.
Basis of VAST
The test is based on the following observations. The finding that fetal cochlear 
apparatus gets mature enough to appreciate acoustic stimulation from 28 weeks of 
gestation. (Smith 1994).
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The observation and assumption that auditory sensation is one of the first to 
get affected by hypoxia (Arulkumaran, 1992).
Methodologic Characteristics
Sound Intensity
Acoustic  impedance  is  higher  in  tissue  and  fluid  than  in  air.  Therefore 
clinicians  should  be  aware  that  the  intrauterine  sound level  during  VAS is  much 
higher than the output sound level measured in air.
Smith et al., studied nine patients at term using an artificial larynx with an 
average output of 84 dB at 1m in air and found that intrauterine peak sound levels 
reached 91 – 111 dB.
Similar Nyman et al., studied 16 patients at term. Their artificial larynx had a 
sound level of 99 dB at a distance of 1m air, and the mean recorded sound pressure 
level inutero was 115 dB. Their highest recorded intrauterine sound level was 129 dB. 
In studies performed on the ewe, Gerhardt et al., reported that a sound pressure level 
of 103 dB correlated with an intrauterine pressure level of 129.7 – 140.9 dB.
Various sound internsities have been used in different clinical studies.  Smith 
et al., used a device with an average sound pressure level of 82dB measured at 1m in 
air  Kisilevsky and  Muir used  a  vibrator  with  a  sound  pressure  level  of  64dB 
measured in air at a distance of 4in. Grade and Lovett used an artificial larynx with 
an output of 100 dB measured in air at a distance of 2in,.  Yao et al., assessed fetal 
response to three different intensity levels; 92, 103 and 109 dB.
Fetal movements as perceived by the mother were significantly greater after 
103  and  109  dB  stimuli  compared  with  the  92  dB  stimulus.  Fetal  heart  rate 
accelerations occurred slightly more often at 109 dB stimulation than at the 92 dB 
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level,  but  the difference was not  significant.  Thus,  depending on the  index being 
evaluated, different requirements must be set. Based on the data presented by Yao et 
al., a  103 dB device  seems to  be  a  suitable  tool  for  evoking  FHR accelerations, 
whereas maternal perception of fetal movements might require a louder sound source.
Duration
Stimulus  application  have  lasted  from 1  –  5  seconds  in  different  studies. 
Pietrantoni  et  al., evaluated  the  effect  of  stimulus  duration  on  the  initial  FHR 
acceleration response following VAS of 1, 3 or 5 seconds. Using an artificial larynx, 
with a sound pressure level  of 83dB measured at  a  distance of 1m, they found a 
significant difference was found between 3 and 5 sec of stimulation. Therefore these 
author suggested that a 3 sec sound stimulus is adequate to evoke a fetal response. 
Most  clinical  studies  have  adopted  these  results  and  have  used  a  standard  3  sec 
stimulus in various clinical situation.
REPETITION RATE
In many studies in which fetuses were stimulated only once, an absence of 
response  was  regarded  as  fetal  non  –  reactivity.  In  other  studies  fetuses  were 
repeatedly stimulated (two to five times) to evoke a response. Further research seems 
necessary to establish a definite criterion so that all conclusions can be standardized.
POSITION OF THE ACOUSTIC STIMULATOR
Virtually identical fetal heart rate response and increases in fetal movement 
were observed after VAS over the fetal vertex or breech. The fetal starle response was 
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uniformly observed in both groups. (Daniel P.Eller, Lucinda J.Robinson, Roger B. 
Newman).
FETAL RESPONSE
Different variable have been used to define fetal response to VAS. The most 
common are FHR accelerations and fetal gross body movements. However in some 
studies, other criterias such as fetal eye blinking, breathing, behavioural states and 
limb movements have been used.
The time lag between the stimulus and the expected fetal response has varied 
between studies. Where as some investigators looked only for immediate changes in 
fetal activity, others followed the fetus for upto 2 hours after stimulations. It should 
also  be  noted  that  the  mode  and  duration  of  the  fetal  response  vary at  different 
gestational ages.
GESTATIONAL AGE
Morphological  studies  have  shown that  by 20 weeks  gestation,  the  human 
cochlea  has  achieved  a  development  status  comparable  to  that  found  in  other 
mammals,  when  the  first  response  to  sound  can  be  readily  evoked.  However, 
investigators could only demonstrate a human fetal response to an acoustic stimulus 
several weeks later. Birnhotz and Benacerraf evaluated the blink-startle response to 
VAS.  Responses  were  first  elicited  between  24-25  weeks  gestation  and  were 
presented consistently after 28 weeks. In the study of Gangon et al., FHR response to 
VAS was noted in 11 to 13 fetuses between 24 – 26 weeks.
Crade and Lovett reported no fetal startle response to VAS before 24 weeks 
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gestation. Between 24 – 27 weeks 30% of fetuses reacted and after 31 weeks, 96% 
reacted  based  on  these  data,  clinicians  should  be  aware  that  normal  and  healthy 
fetuses of less than 30 – 31 weeks gestation might not respond to VAS.
Several investigators have reported FHR changes following VAS. The mode 
of  response  is  probably  related  to  gestational  age.  Jensen found  that  the  FHR 
response  to  VAS  increased  (i.e.a.  larger  FHR  acceleration)  as  gestational  age 
progressed from 32 to 39 weeks. GAGNON et al. reported that before 30 weeks, the 
FHR response was usually characterized by a single prolonged acceleration. After 30 
weeks, there was a significant and prolonged increase in the basal FHR, which lasted 
upto 1 hour. In fetuses of more than 33 weeks gestation, there was also a delayed 
increase in the number of FHR acceleration 10 and 20 minutes after the stimulus. 
Other  studies  documented  an  increase  in  baseline  FHR and  accelerations  in  term 
fetuses.  Gagnon et al.,  noted a negative correlation between the FHR response to 
vibro – acoustic stimulation and the pre-stimulation basal FHR. 
If stimulation was performed during a period of fetal tachycardia, more than 
50% of fetuses responded with an FHR acceleration of less than 15 beats per minute.
The authors therefore concluded that VAS might have limited clinical value in 
tachycardiac  fetuses.  A  fetal  startle  response  was  observed  in  healthy  fetuses 
following  VAS.  The  mother  usually  perceives  this  immediate  fetal  movement. 
THOMAS  et  al.,  found  that  in  preterm  gestations,  mother  perceived  a  fetal 
movement in 87.5% of cases, whereas in term pregnancies the incidence was 96.7%.
In the study of NYMAN and WESTGREN 97% of the mothers noted a fetal 
movement after stimulation. Different results were reported by KISILEVSKY et al., 
In  their  study on  pregnancies  at  23-36 weeks,  mothers  perceived  27  –  75% less 
movement than observed by USG. However, the investigators used a virbator with a 
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low sound output (64 dB), which probably elicited less vigorous fetal movements.
Gagnon et al.,  found that  breathing activity in  the preterm fetus (26 – 35 
weeks gestation) was not affected by VAS in term fetuses, a significant reduction 
inbreathing movements occurred for 1 hour after VAS. Breathing during this period 
was also more irregular than in the prestimulus period.
DEVOE et  al.,  also noted a  decrease in  breathing activity in  term fetuses 
following VAS but did not observe changes in the breathing rate.
BEHAVIOURAL STATES        
Obvious changes in fetal behavioural states have been found following VAS. 
GAGNON et al., performed VAS in 14 fetuses in quiet sleep (State 1F) change to 
active  sleep  (State  2F)  was  noted  in  12  fetuses.  The  remaining  two  fetuses 
demonstrated only isolated. FHR accelerations without a shift in behavioural state. In 
the study of VISSER et al., VAS during state 1F was associated with a state change in 
seven  of  nine  observation  (four  times  into  state  2F,  three  times  into  state  4F). 
Stimulation during state 2F was associated with a change into 4F in four of nine 
observation. In the study of DEVOE et al., all four fetuses, stimulated during state 1F 
moved into state 4F. Of the 16 fetuses stimulated during state 2F, 11 changed to stage 
4F.  VISSER et al., expressed concern as to the safety of VAS because in normal 
unstimulated fetuses, a change from state 1F to 4F is rare and in newborns, such a 
change is associated with painful stimuli.
NEUROLOGICAL STATE ASSESSMENT  
The  normal  neonatal  response  to  sound  stimulus  consists  of  a  generalised 
paroxysmal startle reflex. DIVON et al., and others have shown a similar response in 
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healthy fetuses after VAS. It was therefore suggested that the startle response might 
indicate an intact fetal brainstem.
Habituation is progressive decrease in response that occurs when a stimulus is 
repeatedly presented. There is evidence that a normal habituation pattern may reflect a 
normal central nervous system. Habituation to VAS was reported in normal healthy 
fetuses near term. Fetuses who failed to habituate demonstrate an increased incidence 
of distress and adverse outcome.
It is yet unclear whether the VAS influences the human fetus by auditory or by 
vibratory pathways.  Ohel et al., and Park and Kim evaluated. anencephalic fetuses 
who lacked auditory capabilities. Both studies reported no response to VAS in these 
fetuses. It was therefore assumed that an acoustic mechanism is needed to elicit a fetal 
response.  In  contrast  Gagnon  et  al.,  found  that  a  pure  low  frequency  vibratory 
stimulus applied during episodes of low FHR variability caused a change from a state 
of quiet sleep to a state of rapid eye movement sleep in healthy term fetuses. However 
no fetal response was elicited if the stimulus was delivered during periods of high 
FHR variability.
VAST – An eight – parameter Test
VAST  directly  or  indirectly  elicits  and  thereby  tests  the  following  fetal 
systems or junctions:
• Functional state of CNS
• Reflex CVS response to CNS stimulation
• Startle response / stress response
• Motor response (flexion – extension type of limb movement)




• Fetal learning ability (Habituation)
Antepartum Vibro Acoustic Stimulation 
Antepartum testing of fetal well being based on the response to VAS has been 
extensively studied. READ and MILLER studied a high risk population with sound 
stimuli and oxytocin challenge testing (OCT). When FHR accelerations evoked by 
sound exceeded 15 bpm the subsequent  OCT was always  negative.  Suspicious  or 
positive OCTs were common when there was no response to auditory stimuli.
TRUDNIGER and  BOYLAN found  that  in  high  risk  pregnancies,  an 
impaired response to sound had greater predictive value than a non reactive NST. 
SERAFINE  et  al., reported  that  fetuses  with  spontaneous  or  sound  generated 
reactivity had comparably good outcomes.  On the other  hand,  fetuses  that  lacked 
spontaneous or sound stimulated reactivity had an increased risk for intrapartum fetal 
distress. SMITH et al., reviewed their experience with 7763 tests of antepartum FHR 
recordings. Fetal death occurred within 7 days of a reactive test with an incidence of 
1.9  per  1000  in  patients  received  acoustic  stimulation.  This  finding  contrasted 
favourably with  a  death  rate  of  1.6  per  1000 fetuses  with  spontaneous  reactivity. 
CLARK  et  al.,  performed  4793  antepartum  tests,  17%  of  NSTs  that  were  non 
reactive with sound stimulation were followed by a positive CST or BPP score of 4 or 
less. There was no unexpected antepartum fetal deaths in this study population.
INTRAPARTUM VIBRO – ACOUSTIC STIMULATION  
A  normal  intrapartum  FHR  recording  is  usually  associated  with  good  fetal 
outcome. In contrast, fetal acidosis is not a consistent finding when an ominous FHR 
pattern is recorded. Many perinatal centres routinely determine the pH of the fetal 
scalp blood whenever an abnormal FHR is observed. However, this is an invasive 
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procedure with technical limitations in cases of an undilated cervix. Because VAS is 
non invasive and easy to perform, several investigators have addressed the possibility 
of performing it instead of fetal pH sampling.
Smith et al., studied 64 patients with an abnormal FHR tracing. Thirty fetuses 
responded to VAS with FHR accelerations and all had a scalp pH of 7.25 or greater. 
Of the 34 fetuses who did not respond with FHR acceleration, 18 (53%) had a pH of 
7.25 or less.  Ohel et al., evaluated the fetal response to VAS in 100 women during 
active labour, including fetuses with both normal and abnormal FHR recordings. All 
fetuses  with  FHR  response  to  stimulation,  including  those  with  an  abnormal 
prestimulation FHR tracing, had a good outcome.
Edersehim  et  al., reported  that  fetal  acidosis  (pH  less  than  7.20)  never 
occurred in fetuses that responded to VAS within an FHR acceleration. However, of 
the 72 who did not respond, 39 had a pH greater than 7.25, 27 had a pH less than 7.20. 
Polzin et al., studied 100 patients with an abnormal FHR recording. The meanscalp 
pH was 7.29 in those fetuses who reacted to the stimuli and 7.22 in those who did not. 
Despite this significant difference, the lack of response to VAS predicted a pH less 
than 7.20 in only 39% of patients. Ingermarson and Arul Kumaran obtained similar 
results. In their study, the mean scalp pH values were significantly higher in fetuses 
who showed reactive responses compared with those who demonstrated no response 
or an FHR deceleration (pH of 7.30 and 7.22, respectively).
However, acidotic pH values (7.16 and 7.18) were found in two fetuses that had 
shown a reactive response to VAS. Strong et al. reported a case of intrapartum death 
within 20 minutes of a reassuring acoustically stimulated FHR acceleration. The cause 
of death was sepsis and meconium aspiration.
Zimmer et al., studied the possible effect of maternal analgesia on VAS results. 
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Fetuses  were  stimulated  during  a  quiet  state  following  maternal  intravenous 
administration of meperidine and promethazine. Fetal response in terms of gross body 
movements and FHR accelerations occurred in all 12 patients who were evaluated.
Recently, VAS was used as an admission test in early labour. It was suggested 
that the test could differentiate between the fetuses that is likely to tolerate the stress 
of labour and the fetus that may develop fetal distress.  Ingermarsson et al., found 
that out of 694 fetuses with a normal FHR response to VAS only 12 (1.7%) developed 
distress later in labour. Of the nine fetuses that had an equivocal or ominous FHR and 
did not respond to VAS, five developed fetal distress later. Similarly,  Sarno et al., 
reported that among fetuses that did not react to VAS in the early intrapartum period, 
the incidence of caesarean delivery due to fetal distress was 35.7% and the 1 minute 
Apgar Score was less than 7 in 50% of cases.
The summary,  VAS during labour has high negative predictive value.  That is 
fetuses that respond to VAS usually have a normal outcome. On the other hand, an 
abnormal  response  is  not  an  accurate  predictor  of  adverse  outcome.  Therefore, 
diagnosis of fetal distress is labour based solely on the VAS results should probably 
be avoided.
Acoustic testing is not yet widely used or even studied on a large scale. As a 
results, there are several protocols and methods of interpretation. There have been two 
basic approaches to the use of sound for fetal stimulation.
ACOUSTIC STIMULATION TEST AS A REPLACEMENT FOR THE NST   
In the first approach, the acoustic test was evaluated as a replacement for NST; 
the reactivity criteria are those of the classic NST. The practicality of the acoustic test 
was  assessed  by comparing  340  patients  undergoing  NST with  366  patients  who 
received acoustic stimulation (upto 3 seconds in duration) by an artificial larynx after 
monitoring the heart rate for 5 minutes.
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The stimulus was repeated at 1 minute intervals for an arbitary maximum of 
three times if  no ‘qualifying  accelerations’  (presumably the absence  of  a  15 bpm 
acceleration lasting 15 seconds) response occurred. A reactive test was defined as the 
presence of atleast two 15 bpm accelerations lasting 15 seconds in a 10 minute period. 
76% of  term fetuses  responded with one stimulus;  15% required  two stimuli  and 
approximately 9% required, three stimuli. Using the acoustic test, the incidence of 
non reactive test was reduced from 14% (Classic NST) to 9%. Reduced testing time 
(mean of 27 minutes with a reactive NST vs. 20 minutes with a reactive acoustic test) 
was also noted.
VAST AS A FOLLOW – UP OF THE NON REACTIVE NST.  
Kathleen et al.,  have evaluated acoustic testing prospectively by comparing 
the outcome of fetuses, with either a non reactive acoustic test or a reactive acoustic 
test following a non reactive NST. With the outcomes of control fetuses who had non 
reactive NSTs and were evaluated and managed in the traditional manner using the 
OCT / CST. As a part of the analysis of the predictive ability of the acoustic test, this 
study addressed whether the stimulation of a fetus with non reactive tracing might 
result in artificial reactivity with a consequent high incidence of false – negative tests. 
This study demonstrated that the addition of the acoustic test improved discrimination 
over NST testing alone.
SAFETY OF VAST
Despite extensive research over the last decade, there is still concern as to the 
safety of VAS. As previously noted, both human and animal studies have found that 
the intrauterine sound level evoked by an artificial  larynx is much higher than its 
output in air. In fact, the fetus is exposed to sound levels similar to those generated by 
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a jet airplane at takeoff. In an attempt to establish the safety of this device.  Ohel et 
al.,  tested  the  auditory  nerve  and  brain  stem evoked  responses  in  neonates  after 
intrauterine VAS and failed to document any evidence of hearing loss.
Arulkumaran et al., evaluated the auditory acuity in 465 children at the age 
of 4 years and also reported no hearing impairment that could be attributed to VAS. 
Several case reports have described severe fetal  distress following VAS. Vigorous 
fetal movements evoked by the stimulus may result in tightening of a nuchal cord, 
bradycardia and subsequent caesarean for fetal distress.
Visser et al., studied fetal behavioural states after VAS and noted that some 
fetuses moved from state 1F and 4F. Such state transition were not observed in near 
term low risk fetuses before stimulation and therefore were deemed nonphysiologic. 
Furthermore,  on  several  occasions,  an  atypical  FHR  pattern  was  recorded  and 
disorganization of behavioural states was observed. The authors suggested that pain 
perception might cause these changes.
Recently, Zimmer et al., reported that VAS was followed by immediate fetal 
micturition. (Zimmer EZ, Chao CR, Guy GP, Marks F, Fifer WP VAS stimulates 
human fetal voiding). Micturition is an accepted measure of emotionality. Therefore, 
it is possible that VAS causes pain and stress in the fetus. Abrams et al., questioned 
the safety of VAS when they noted an increase in brain glucose metabolism after 
sound stimuli.  It  was  suggested that  the  increased  glucose uptake associated with 
VAS is anaerobically metabolized by a process that increased lactate production in the 
fetal brain. Such an increase may be harmful in a fetus that is already in distress, has 
an abnormal FHR tracing, and is exposed to VAS in an attempt to differentiate a true 
positive FHR abnormality from a false positive tracing.
Despite these concerns, Nyman et al., concluded that intrauterine exposure to 
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VAS did not result in impaired neurological development or hearing loss.
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MATERIALS AND METHODS
The study was conducted  in  the  labour  ward of  Government  Hospital 
for Women and Children, Institute of Obstetrics, MMC, Chennai for a period 
of 2 years from February 2004 – January 2006.
The study was  conducted  for  assessing  the  role  of  VAST in  the  fetal 
monitoring of term high risk pregnancies in early labour in 400 patients.
INCLUSION CRITERIA 
1. All singleton cephalic presentations
2. After 37 completed weeks in early labour
3. Medical illness complicating pregnancy like hypertension, anemia, Rh 
incompatibility, gestational diabetes mellitus, and Heart disease
4. Obstetric complications like pre-eclampsia, ante – partum hemorrhage, 
fetal growth restriction and post EDD pregnancies.
Exclusion Criteria 
1. USG showing evidence of congenital anomaly 
2. Malpresentations

















After  all  these  preliminary  measures,  all  patients  were  subjected  to  VAST. 
Fetal  heart  rate tracing were recorded 5 minutes before and 10 minutes after 
fetal  acoustic stimulation.  The reactivity of the traces was analysed with the 
perinatal outcome, taking Apgar scores at 1 and 5 min as a marker.
CARDIOTOCOGRAPHY
Consists of 
1. Ultrasound transducer 
2. Tocodynamometer
3. Transducer belt and buckle set
4. Chart paper 25 mt roll
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5. Ultrasound coupling gel
6. AC line cord
After fixing the fetal heart transducer on the mothers abdomen, she is asked to 
turn  slightly  and lie  on  her  left  side  or  use  pillow under  one  of  her  hips  to 
displace  the  weight  of  the  uterus  away  from  the  IVC.  The  patients  blood 
pressure is recorded every 10 minutes during the procedure.
The  remote  event  marker  is  then  given  in  her  hand  so  that  she  can 
indicate  her  perceived  FM  by  pressing  its  button.  The  transducer  belt  for 
uterine contraction is tied around the abdomen over the fundus. 5 minutes of 
non stress CTG is done.
At the end of this period, the fetus is given a vibroacoustic stimulation 
with the help of  an acoustic  stimulator  using 82dB at  80 Hz for  a period of 
three  seconds  on  the  maternal  abdomen  over  the  fetal  head  and  the 
acceleration in the fetal heart rate is observed.
If  the  qualifying  acceleration  fails  to  occur  with  one  stimulus,  same 
stimulus reapplied at 1 min intervals for a maximum of three times. If reactive 
criteria are met, monitor for atleast 5 minutes after stimulation.
If  reactive  criteria  not  met  even  after  repeat  stimulation,  trace 
interpreted as non reactive.
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VAST INTERPRETATION CRITERIA  
Type I - Prolonged (at least 3 minutes) acceleration by 15 BPM above 
the baseline
Type II - Two  accelerations  by  15  BPM  and  lasting  for  atleast  15 
seconds over 10 minutes period or one such acceleration over 
the same period but lasting for atleast 1 minute
Type III - Biphasic  response  is  an  acceleration  followed  by  a 
deceleration of usually 60 BPM magnitude from the baseline 
lasting for 60 seconds 
Type IV - No acceleration at all
Type V - Deceleration following the stimulus
Type I & II- Reactive
Type III, IV 





Age (Yrs) R VAST NR VAST Total
< 20 26 3 29
20 – 25 219 68 287
26 – 30 55 13 68
31 – 35 10 2 12
> 35 3 1 4
Among  the  400  patients  who  were  included  in  the  study,  majority  of 
them, 287 were between 20 – 25 years of age.
PARITY DISTRIBUTION
Parity Reactive VAST Non reactive 
VAST
Total %
Primi gravida 193 64 257 64
Multi gravida 120 23 143 36
Majority of patients were primi gravida 257 (64%).
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VAST – TRACING PATTERNS
VAST Number %
Reactive (R) 313 78
Non reactive (NR) 87 22
VAST tracing were recorded for 10 minutes after  the stimulus. Of the 
400  patients,  313  (78%)  had  a  reactive  trace  in  contrast  to  87  (22%)  traces 
which were NON – REACTIVE. 
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AMNIOTIC FLUID CHARACTER
Colour of Liquor Number %
Clear 325 81
Thin meconium 35 9
Thick meconium 40 10
Of the 400 patients who were followed to delivery after VAST 325 (81%) had 
clear liquor, 35 (9%) had thin meconium, and 40 (10%) had thick meconium 
stained liquor.
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VAST VS LIQUOR CHARACTER
Colour Of Liquor R VAST NR VAST TOTAL
Clear 273 (87%) 52 (60%) 325
Thin Meconium 26 (9%) 9 (10%) 35
Thick meconium 14 (4%) 26 (30%) 40
X2 = 50.6 P = 0.001
Among  clear  liquor,  VAST was  reactive  in  84% and  non  reactive  in 
16%.
Among non reactive VAST 30% had thick meconium stained liquor.
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TEST – DELIVERY INTERVAL (HOURS)
Test Delivery Interval 
(hrs) R VAST NR VAST TOTAL
≤ 2 hours 15 33 48 (12%)
2 hrs 1min – 4 hrs 63 22 85 (21%)
4 hrs 1min – 6 hrs 73 18 91 (23%)
> 6 hrs 162 14 176 (44%)
X2 = 39.1 P = 0.001
The  patient  were  selected  in  early  intrapartum  period.  Majority  of 
patients  with  reactive  VAST  delivered  later  than  6  hrs  after  the  test.  In 
selected  cases  (33%) where  fetal  distress  was  indicated by a  Non – reactive 
VAST  or  meconium  staining  of  the  liquor.  Earlier  intervention  was 
undertaken. They were delivered within 2 hrs.
From the studies of  Arul Kumaran et  al., it  has been shown that  the 
best correlation between the test and fetal outcome was seen when the test – 
delivery interval was 6 hours or less.
MODE OF DELIVERY
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Mode of delivery Number %
Labour natural 225 56
Forceps 15 4
LSCS 160 40
225 patients (56%) were delivered by Labour Natural, while caesarean 
sections  were  performed  for  160  patients  (40%)  and  15  (4%)  patients  were 
delivered by forceps. Fetal distress was the main indication for termination by 
LSCS and forceps.
CAESAREAN RATES
Indications R VAST NR VAST Total
Fetal distress 29 (43%) 39 (57%) 68 (100%)
Others 83 (90%) 9 (10%) 92 (100%)
112 48 160
 X2 = 43.14 P = 0.001
Of the 112 patients (LSCS) with reactive VAST 29 patients (26%) had 
fetal distress for their indication. Those were taken for caesarean     6 hours 
after  test.  Of  the  48  patients  (LSCS)  with  non –  reactive  VAST 39 patients 
(81%) had fetal distress for their indication.
Of the LSCS for the fetal distress 29 patients in reactive VAST group. 
39 patients in the non reactive VAST group.
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MODE OF DELIVERY IN RELATION TO VAST
Mode of 
Delivery
Reactive VAST Non reactive vast
No % No %
Total
LN 190 61 35 40 225
Forceps 11 3 4 5 15
LSCS 112 36 48 55 160
X2 = 11.7 P = 0.002
Of  the  patients  subjected  to  VAST  190  patients  (61%)  were  delivered   by 
labour natural.
11 (3%) by forceps, 
112 (36%) by LSCS following reactive VAST 
Of the non reactive VAST 35 patients (40%) were delivered by labour natural 
while 48 (55%) and 4 (5%) were delivered by LSCS and forceps respectively.
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HIGH RISK PREGNANCIES





Post EDD (Post EDD) 128 28 156 (39%)
Mild Preeclampsia 64 14 78 (19.5%)
Post EDD Mild PE 17 4 21 (5%)
Mild PE and Others 13 - 13 (3%)
Oligohydramnios + JUGR 25 14 39 (10%)
Oligohydramnios+Others 17 4 21 (5%)
Severe preeclampsia 15 6 21 (5%)
GDM complicating 5 4 9 (2%)
Other complications
(Anemia, Heart disease, 
APH)
29 13 42 (11.5%)
The study was conducted in  High risk pregnant  patients.  Among 400, 
177 (44%) patients  had crossed EDD, 112 patients  (28%) were preeclamptic 
patients and 60 patients (15%) were complicated by oligohydramnios. Few (9) 
had  Gestational  Diabetes  mellitus  complicating  pregnancy.  The  rest,  42 
patients had other high risk factors like anemia, placenta previa, heart disease, 
epilepsy and recurrent pregnancy loss.
BIRTH WEIGHT DISTRIBUTION
Birth  weight (kgs) R VAST NR VAST Number %
< 2 kg 2 4 6 1
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2.0 – 2.5 65 28 93 23
2.6 – 3 130 31 161 40
3.1 – 3.5 97 17 114 29
 3.6 – 4 15 7 22 7
> 4 kg 4 - 4 1
Among the  400 patients  who were  followed to  delivery most  patients 
(161)  delivered  babies  with  birth  weight  between  2.6  –  3  kgs.  6  babies 
weighed less than 2 kg and 4 babies weighed more than 4 kg. The mothers of 




≥ 7 373 93
5 and 6 21 5
≤ 4 6 2
NICU 38
The apgar  score  were 7 and above in  373 babies  (93%) 21 (5%) babies  had 
moderate asphyxia with an apgar of 5 and 6 while 6 (2%) babies had severe 
asphyxia  with  an  apgar  less  than  /  equal  to  4  of  the  38  babies  admitted  to 
NICU,  18  babies  only admitted  for  birth  asphyxia.  Other  were  admitted  for 
IUGR care and GDM care.
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APGAR IN RELATION TO VAST
Apgar Reactive VAST Non reactive 
VAST
No. % No %
Total
≥ 7 302 96 71 81 373
5 and 6 9 3 12 14 21
≤ 4 2 1 4 5 6
X2 = 23.9 P = 0.001
Among 313 patients with reactive trace. 302 babies (96%) had good apgar. 9 
and 2 babies had moderate and severe asphyxia respectively.
Among 87 patients with non – reactive trace. 71 babies (81%) had good apgar. 
12 and 4 babies were moderately and severely asphyxiatd respectively.
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INCIDENCE OF FETAL DISTRESS AND NICU ADMISSION
FETAL DISTRESS R VAST NR VAST
Incidence 35 (11%) 42 (48%)
NICU 3 9
Fetal distress was low in patients with reactive VAST i.e. 11%. 
Of the 35, 29 delivered by CS, 6 babies delivered by forceps. Highest 
incidence of fetal distress was encountered with non – reactive VAST which 
is 48%. 
Of  the  42,  39  were  delivered  by  CS  3  were  delivered  by  forceps 
delivery.
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Non – reactive 33 54 87
Reactive 21 292 313
Total 54 346 400
X2 = 56.8 P = 0.001
Normal outcome 292 (93.4%)
Reactive VAST (313)
Abnormal outcome 21 (6.6%)
Normal outcome 54 (62%)
Reactive VAST (87)
Abnormal outcome 33 (38%)
95 % Confidence Interval
Sensitivity - 61% 47 - 74
Specificity - 84% 80 - 88
PPV - 38% 27 - 49
NPV - 93% 90 - 96
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False Positive - 15% 12 - 20
False negative - 39% 26 - 53
The factors which were considered as abnormal outcome are:  a 5 min Apgar 
score less than 7, thick meconium stained amniotic fluid or admission to the 
neonatal intensive care unit. In the VAST reactive group of 313 patients, only 
21 babies were found to be with poor fetal outcome which constitutes 6.6%.
In the VAST non – reactive group of 87 patients 38% of the babies 
were found to be with poor fetal outcome. Of the 16 babies delivered with low 
apgar, 3 babies had hypoxic ischemic encephalopathy. Details of the babies 
are as follows.
1. S.No.174 -  NR VAST showing meconium staining  of  liquor.  Emergency 
LSCS was done to  deliver the baby which was severely asphyxiated (TD 
interval – 30 min). Discharged on 7th POD. B.wt – 2 kg.
2. S.No.87  -  NR  VAST  with  clear  liquor.  Baby  was  delivered  by  labour 
natural with episiotomy with 1/10, 3/10, 8/10 apgar (TD interval – 5hrs 30 
min) B.wt – 3.1 kg which was discharged on 11th PND after admission to 
NICU.
3. S.No.94  -  NR  VAST with  clear  liquor  delivered  labour  natural  an  alive 
asphyxiated baby of low apgar (TD interval  – 5 hours) which discharged 
from NICU on 6th PND.
All the above babies are in follow up. 
In  non  reactive  VAST  group  only  one  baby  expired  –  details  are  non 
reactive VAST showing thick meconium stained liquor. Emergency LSCS was 
done  to  delivery  the  baby  which  was  severely  asphyxiated.  (TD  interval  5 
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hours) admitted in NICU. Expired on 3rd POD due to MAS. 
In  the  study,  only  one  baby  expired.  Details  are  1.R  VAST  with  clear 
liquor.  Delivered  by  low  mid  cavity  forceps.  Alive  moderately  asphyxiated 
baby of apgar 6/10 which was admitted in NICU and connected to ventilator 
(T.D. interval 10 hours) B.wt – 3 kg. baby expired on 3rd PND of severe HIE 
due to severe intra partum birth asphyxia.
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DISCUSSION
Sarno  and  co  –  workers studied  201  women  who  had  VAS induced 
FHR accelerations in early labour  and found that the failure to respond may 
predict subsequent fetal condition. Non response was associated with positive 
predictive  value  of  50%,  50%  and  14%  for  meconium  passage,  caesarean 
sections for fetal distress and apgar scores less than 7 respectively. Negative 
predictive values  were better  at  78%, 88%, and 98% for meconium passage, 
caesarean section for fetal distress and apgar scores less than 7 respectively.
In the  present  study,  400 patients  with  high  risk pregnancies  in  early 
labour  were  taken.  Non  response  was  associated  with  positive  predictive 
values of 40%, 45% and 18% for meconium passage, CS for fetal distress and 
Apgar scores less than 7 respectively.  Negative predictive values were better 
at 87%, 90% and 96% for meconium passage, CS for fetal distress and apgar 
scores less than 7, respectively.
Nyman and co – workers studied FHR monitoring in response to VAS 
as  a  test  to  fetal  wellbeing  in  a  population  of  gravidae  with  high  risk 
pregnancies  (n  –  517)  admitted  to  high  risk  ward.  The  sensitivity  and 
specificity was 81% and 89% respectively.
T annirandorn and co-workers studied FHR reactions to the FAST in 
140 women in early labour. All were with a singleton, vertex presenting fetus, 
and GA ranged from 37 – 43 weeks. The results of VAST were compared with 
fetal outcome which was considered poor when there was perinatal death, a 5 
min  Apgar  less  than  7,  thick  MSAF  or  admission  to  the  NICU.  FAST  has 
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better  sensitivity  (71.4%),  specificity  (99%),  PPV  (80%)  and  NPV  (98.5%) 
for poor fetal outcome. In  Ingemarsson  and Arulkumaran study for VAST, 
sensitivity,  specificity,  PPV  and  NPV  were  60%  71%,  27%  and  91% 
respectively.
In  the  present  study,  the  role  of  VAST  in  predicting,  poor  fetal  outcome 




1. 400 cases  of  High risk  pregnant  women after  37  completed  weeks  in 
early labour were recruited for the study.
2. All  the  cases  were  clinically  examined  routine  ultrasonogram  was 
performed for gestational age and liquor status.
3. Vibro  –  acoustic  stimulation  was  performed  using  an  electronic 
artificial  larynx  in  all  these  cases  and  the  tracings  were  classified  as 
reactive  and  non  reactive  based  on  the  fetal  heart  acceleration  to  the 
acoustic stimuli.
4. In the non – reactive VAST traces cases, early artificial rupture of the 
membrane was performed to see the colour of liquor.
5. The mode of delivery and test delivery interval was noted.
6. The  adverse  perinatal  outcome  was  analysed  with  relevance  to  the 
thick meconium stained liquor, and Apgar score of < 7.
In the present study majority were primigravida in the age group of 20 – 
25 years.
Of the 400 patients 78% had reactive and 22% had non – reactive VAST.
Among clear liquor, VAST was reactive in 84% and non reactive in 16%. 
Among thick  MSL, VAST was reactive  in  35% and NR in  65%.  VAST non 
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reactive in 60% of clear liquor and 40% meconium stained liquor.   
In selected cases (33 patients) where fetal distress was indicated by non 
reactive  VAST  or  meconium  staining  of  liquor,  earlier  intervention  was 
undertaken. They were delivered within 2 hours by Emergency LSCS.  
 Among  those  two  were  moderately  asphyxiated  and  1  was  severely 
asphyxiated and admitted in NICU. The rest had good apgar because of 
earlier intervention.
 Of the  patients  subjected  to  VAST 61% were  delivered  by LN while 
3%  and  36%  were  delivered  by  LSCS  and  forceps  respectively 
following reactive VAST.
 Of  the  non  reactive  VAST group  more  than  half  delivered  by  LSCS. 
Among those 79% babies had good Apgar.   
 Among  patients  who  undergone  CS  for  fetal  distress  57%  had  non 
reactive VAST and 43% had reactive VAST.
 The study was conducted in High risk pregnancy patients. Among 400 
patients,  44% had  crossed  EDD.  28% were  preeclamptic  patients  and 
15% were complicated by Oligo hydramnios. Few had GDM. The rest 
had  high  risk  factor  like  anemia,  placenta  previa,  heart  disease, 
epilepsy, BOH.
 Most patients (40%) delivered babies with birth weight between 2.6 – 3 
kg.  24%  were  low  birth  weight  babies  and  1%  macrosomic  babies 
whose mother had GDM. 
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 Among patients  with  reactive  VAST 96% babies  had  good apgar  and 
4% only had apgar < 7. 
 It  indicates  reactive  VAST  was  associated  with  high  specificity  and 
negative predictive value.
Among patients with non reactive VAST 81% babies had good apgar and 
19%  babies  had  apgar  <  7.  It  indicates  VAST  was  associated  with  low 
sensitivity and positive predictive value.
Incidence of fetal distress was highest with non reactive than with reactive 
VAST (11%).
The factors that were considered as abnormal outcome are : a 5 min apgar 
score less than 7, thick meconium stained liquor or admission to the NICU.
In reactive VAST group 93.4% of babies had good fetal outcome. It gives 
assurance that reactive response indicates fetal well being.
In non reactive  VAST group,  38% of  babies  had poor  fetal  outcome and 
62% had good fetal outcome.




 Vibroacoustic stimulation in the early intrapartum period may be used 
as a non invasive screening method for rapid intrapartum assessment of 
fetal well being.
 It  gives  an  early  prediction  of  fetal  compromise  in  high  risk 
pregnancies
 A reactive response to VAST was associated with high specificity and 
negative  predictive  value.  VAST was  associated  with  low  sensitivity 
and positive predictive value.
 In  the  abnormal  VAST,  high  correlation  with  adverse  perinatal 
outcome was seen.
 In  crowded  labour  rooms  with  limited  monitors  as  in  teaching 
hospitals,  the  VAST  is  very  useful  to  detect  high  risk  cases  and  to 
monitor them effectively and helps the obstetricians in the appropriate 
and timely intervention.
 It  is  therefore  suggested  to  add  VAST to  NST monitors  in  the  busy 
labour  rooms  which  allow immediate  intervention  to  be  taken  in  non 
reactive traces.
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